Balentine LLC Moderna, Inc. Transaction History

Balentine LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $131,772 - $178,509	1,112 Added 82.8%	2,455 $298,000
Q1 2023 May 11, 2023	SELL	$135.66 - $197.02 $34,864 - $50,634	-257 Reduced 16.06%	1,343 $206,000
Q4 2022 Jan 31, 2023	BUY	$118.38 - $210.04 $189,408 - $336,064	1,600 New	1,600 $287,000
Q2 2022 Oct 26, 2022	SELL	$117.13 - $176.59 $164,099 - $247,402	-1,401 Reduced 41.92%	1,941 $277,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $164,099 - $247,402	-1,401 Reduced 41.92%	1,941 $277,000
Q1 2022 Oct 26, 2022	BUY	$126.46 - $235.05 $177,170 - $329,305	1,401 Added 72.18%	3,342 $576,000
Q1 2022 May 06, 2022	BUY	$126.46 - $235.05 $156,810 - $291,462	1,240 Added 58.99%	3,342 $576,000
Q4 2021 Oct 26, 2022	BUY	$225.82 - $368.51 $36,357 - $59,330	161 Added 8.29%	2,102 $534,000
Q4 2021 Feb 02, 2022	BUY	$225.82 - $368.51 $474,673 - $774,608	2,102 New	2,102 $534,000
Q3 2020 Nov 02, 2020	SELL	$54.34 - $94.85 $4,510 - $7,872	-83 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $2,462 - $6,640	83 New	83 $5,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Balentine LLC, based on Form 13F filings with the SEC.

Stay updated on Balentine LLC with notifications on news.